ARS Pharmaceuticals (SPRY) Inventory Average (2024 - 2026)
ARS Pharmaceuticals (SPRY) posted Inventory Average of $8.6 million for Q1 2026, up 6.41% sequentially from $8.1 million in Q4 2025, and up 37.69% YoY from $6.2 million in Q1 2025.
ARS Pharmaceuticals (SPRY) Inventory Average (2024 - 2026) Analysis & Trends
ARS Pharmaceuticals has reported Inventory Average for 3 years, with the latest figure at $8.6 million in Q1 2026.
- Quarterly Inventory Average rose 37.69% year-over-year to $8.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.6 million (up 37.69% YoY) and the FY2025 annual result came in at $6.8 million, changed N/A from the prior year.
- Inventory Average grew to $8.6 million in Q1 2026 per SPRY's latest filing, from $8.1 million in the prior quarter.
- Over five years, Inventory Average peaked at $8.6 million in Q1 2026 and troughed at $3.0 million in Q4 2024.
- A 3-year average of $7.0 million and a median of $8.0 million in 2025 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2025 and 2026: Inventory Average surged 172.5% in 2025, then surged 37.69% in 2026.
- Over 3 years, Inventory Average stood at $3.0 million in 2024, then surged by 172.5% to $8.1 million in 2025, then increased by 6.41% to $8.6 million in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $8.6 million, $8.1 million, and $8.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | ARS Pharmaceuticals | 561.88 Mn | 418.03 Mn | - | 10.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.25 Mn |
| Mar 31, 2026 | 8.59 Mn |
| Dec 31, 2025 | 8.08 Mn |
| Sep 30, 2025 | 8.26 Mn |
| Jun 30, 2025 | 8.00 Mn |
| Mar 31, 2025 | 6.24 Mn |
| Dec 31, 2024 | 2.96 Mn |